Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on June 23, 2025

MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development
CARMEL, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …

Kestra Medical Technologies Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
KIRKLAND, Wash., June 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that the company will be added to the Russell 3000® Index, with automatic …

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update
Held Type C meeting with FDA on Planned New Drug Application (NDA) Submission, Including Clinical, Non-clinical, and Chemistry, Manufacturing, and Control (CMC) Requirements NDA On Track for Submission to FDA in First Half of Calendar 2025 NDA to be …

DMC Global Announces James O’Leary is Appointed as Permanent President & CEO After Leading Company on an Interim Basis
BROOMFIELD, Colo., June 23, 2025 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today announced that James O’Leary has agreed to serve as permanent president and CEO, in addition to his role as executive chairman. Mr. O’Leary has served as DMC’s …

GDEV Announces Change in Leadership
LIMASSOL, Cyprus, June 23, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), today announced that Olga Loskutova will depart from her role as Chief Operating Officer effective …

Oxbridge / SurancePlus Commences Strategic Review of Potential Digital Asset Treasury and SurancePlus Carve Out
GRAND CAYMAN, Cayman Islands, June 23, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, …

DeFi Development Corp. Partners with Kraken to Tokenize DFDV Stock on Solana, Becoming the First U.S.-Listed Crypto Treasury Strategy to Go Onchain
BOCA RATON, FL, June 23, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a landmark partnership with …

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador
Partnership supports near-term launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, June 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Annika …

Brera Holdings Completes Final Closing and Acquires 52 Percent Majority Ownership Stake in Storied Italian Serie B Football Club SS Juve Stabia srl “The Second Team of Naples”
Juve Stabia Club President Andrea Langella (left) with Brera Holdings PLC Executive Chairman Daniel McClory (right) Dublin, Ireland, and Naples, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC ("Brera Holdings," “Brera” or the “Company”) ( …

Capital Vacations Leads a New Era of Vacation Ownership: Transparent, Flexible, and Club Member-Focused
Capital Vacations is redefining what it means to be a Vacation Ownership Club Member MYRTLE BEACH, SC, UNITED STATES, June 22, 2025 /EINPresswire.com/ -- Capital Vacations, a recognized leader in resort management and vacation ownership services, is …

ASML reports transactions under its current share buyback program
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …

Abacus Global Management Announces New Corporate Commercial Campaign at Recent Investor Day in NYC
ORLANDO, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, announced the public launch of their new corporate-focused commercial campaign on …

Xcel Brands Announces Strategic Partnership with Global Fashion Icon Coco Rocha
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ: XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and livestreaming, is proud to announce a …

Guardforce AI Strengthens Decade-Long Client Relationships by Securing Long-term Contract with Government Savings Bank
NEW YORK, NY, June 23, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (Nasdaq: GFAI, GFAIW) (“Guardforce AI” or the “Company”), a global integrated security solutions provider specializing in secured logistics, AI, and Robot-as-a-Service (RaaS), today …

Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)
Oral presentation highlighted the post-hoc analysis during the “Interventions to Prevent Hypoglycemia: Bench to Bedside” session Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia events, particularly in patients …

Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases
Initial pharmacological data from placebo-controlled, double-blind Phase I study shows significant T cell suppression and a favourable safety profile at dosing level of 0.9 mg/kg The substantial reduction in T cell activity highlights the potential …

Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
HOUSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) (the “Company”) today announced that it has entered into a definitive agreement with certain investors (the “SPA”) for the purchase and sale of an aggregate of 610,399 …

Opus Genetics Awarded Non-Dilutive Funding from the RD Fund to Support Preclinical Development of OPGx-MERTK Program
RESEARCH TRIANGLE PARK, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule …

Nano Labs Plans to Apply for License for HKD and Offshore RMB Stablecoin Businesses
HONG KONG, June 23, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced that it plans to apply for relevant licenses to operate …